GSDME and hepatocellular carcinoma: Ibrutinib 77 is a specific Bruton’s tyrosine kinase inhibitor used as a pyroptotic agent in chronic lymphocytic leukemia, HCC, and lung adenocarcinoma through caspase-3/GSDME activation [191–193].